Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Janssen Research & Development, LLC
Indiana University
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Northwestern University
Northwestern University
Mayo Clinic
NYU Langone Health
University of Arizona
Rutgers, The State University of New Jersey